(72 days)
Not Found
No
The document describes standard AED functionality involving ECG analysis and shock delivery based on pre-defined algorithms, with no mention of AI or ML.
Yes
The device is an automated external defibrillator (AED) intended for emergency treatment of sudden cardiac arrest, which directly delivers therapy (electrical shock) to correct heart rhythm.
Yes
The device analyzes the patient's electrocardiogram (ECG) to determine if a shock is needed, and also monitors the ECG rhythm post-resuscitation, which are diagnostic functions.
No
The device description explicitly states it is a "portable, battery operated, automated external defibrillator (AED)" and mentions hardware components like electrodes (pads) and an adaptor cable. This indicates it is a physical medical device with integrated software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Powerheart AED G3 and G3 Automatic are designed to analyze the patient's electrocardiogram (ECG) and deliver an electrical shock to treat sudden cardiac arrest. This is a direct intervention on the patient's body, not a test performed on a sample outside the body.
- Intended Use: The intended use clearly states it's for the "emergency treatment of victims exhibiting symptoms of sudden cardiac arrest." This is a therapeutic intervention, not a diagnostic test.
- Device Description: The description focuses on the device's ability to analyze ECG and deliver a shock, not on analyzing bodily fluids or tissues.
Therefore, the Powerheart AED G3 and G3 Automatic fall under the category of therapeutic medical devices, not in vitro diagnostic devices.
N/A
Intended Use / Indications for Use
The Powerheart AED G3 and the Powerheart AED G3 Automatic devices are intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physicianauthorized emergency medical response.
The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Postresuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of ECG rhythm. If a shockable ventricular tachyarrhythmia recurs, the device will charge automatically and advise the operator to deliver therapy (G3) or automatically deliver the charge (G3 Automatic).
When the patient is a child or infant up to 8 years of age, or up to 55 lbs (25kg), the device should be used with the Model 9730 Pediatric Attenuated Defibrillation Electrodes. The therapy should not be delayed to determine the patient's exact age or weight.
Product codes
MKJ
Device Description
The Powerheart® AED G3 and G3 Automatic are portable, battery operated, automated external defibrillators (AED). After applying the AED's electrodes (pads) to the patient's bare chest, the AED automatically analyzes the patient's electrocardiogram (ECG) and advises the operator to press the button and deliver a shock if needed. The AED uses one button and guides the operator through the rescue using a combination of voice prompts, audible alerts, and visible indicators. For the Powerheart AED G3 Automatic, the AED automatically delivers a shock if needed.
The Cardiac Science G3 AEDs may be used in conjunction with an adaptor cable that allows the use of AAMI DF-80 compliant electrodes other than the Cardiac Science brand. This adaptor cable is provided as an accessory to the Cardiac Science AEDs.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
child or infant up to 8 years of age
Intended User / Care Setting
personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physician-authorized emergency medical response.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Representative samples of the device and adapter cables were tested in accordance with the system, safety, functional and performance specifications. All samples successfully passed.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5310 Automated external defibrillator system.
(a)
Identification. An automated external defibrillator (AED) system consists of an AED and those accessories necessary for the AED to detect and interpret an electrocardiogram and deliver an electrical shock (e.g., battery, pad electrode, adapter, and hardware key for pediatric use). An AED system analyzes the patient's electrocardiogram, interprets the cardiac rhythm, and automatically delivers an electrical shock (fully automated AED), or advises the user to deliver the shock (semi-automated or shock advisory AED) to treat ventricular fibrillation or pulseless ventricular tachycardia.(b)
Classification. Class III (premarket approval)(c)
Date PMA or notice of completion of PDP is required. A PMA will be required to be submitted to the Food and Drug Administration by April 29, 2015, for any AED that was in commercial distribution before May 28, 1976, or that has, by April 29, 2015, been found to be substantially equivalent to any AED that was in commercial distribution before May 28, 1976. A PMA will be required to be submitted to the Food and Drug Administration by April 29, 2015, for any AED accessory described in paragraph (a) that was in commercial distribution before May 28, 1976, or that has, by April 29, 2015, been found to be substantially equivalent to any AED accessory described in paragraph (a) that was in commercial distribution before May 28, 1976. Any other AED and AED accessory described in paragraph (a), shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
0
SEP 1: 0 2009
:
K691943 Cardiac Science Corporation.
Bothell, WA Special 510(k)
June 4, 2009
1/2
:
���. 510(k) Summary
| Submitter: | Cardiac Science Corporation
3303 Monte Villa Parkway
Bothell, WA 98021-8969 |
|------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Beverly Magrane
Phone: (425) 402-2365
Fax: (425) 402-2017 |
| Date Prepared: | June 4, 2009 |
| Trade Name: | Powerheart® AED G3 (Model 9390E)
Powerheart® AED G3 Automatic (Model 9390A) |
| Classification
Name and Number: | Automated External Defibrillator
Class III, 21CFR 870.5310 |
| Product Code: | MKJ |
| Predicate
Device(s): | The Powerheart® AED G3 manufactured by Cardiac
Science, Inc is substantially equivalent to the Cardiac
Science Powerheart AED G3, K052161 (10/21/2005) and
to the FirstSaveTM STAR BiphasicTM AED, K010214,
(2/22/2001), manufactured by Survivalink Corporation. |
| Device
Description: | The Powerheart® AED G3 and G3 Automatic are
portable, battery operated, automated external
defibrillators (AED). After applying the AED's electrodes
(pads) to the patient's bare chest, the AED automatically
analyzes the patient's electrocardiogram (ECG) and
advises the operator to press the button and deliver a
shock if needed. The AED uses one button and guides
the operator through the rescue using a combination of
voice prompts, audible alerts, and visible indicators. For
the Powerheart AED G3 Automatic, the AED
automatically delivers a shock if needed.
The Cardiac Science G3 AEDs may be used in
conjunction with an adaptor cable that allows the use of
AAMI DF-80 compliant electrodes other than the Cardiac |
:
4
1
Cardiac Science Corporation. Bothell, WA Special 510(k) June 4, 2009
691943
Indications For Use:
Functional and Safety Testing:
Conclusion:
Science brand. This adaptor cable is provided as an accessory to the Cardiac Science AEDs.
The Powerheart AED G3 and the Powerheart AED G3 Automatic devices are intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physician-authorized emergency medical response.
The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Post-resuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of ECG rhythm. If a shockable ventricular tachyarrhythmia recurs, the device will change automatically and advise the operator to deliver therapy (G3) or automatically deliver the charge (G3 Automatic).
When the patient is a child or infant up to 8 years of age, or up to 55 lbs (25kg), the device should be used with the Model 9730 Pediatric Attenuated Defibrillation Electrodes. The therapy should not be delayed to determine the patient's exact age or weight.
Representative samples of the device and adapter cables were tested in accordance with the system, safety, functional and performance specifications. All samples successfully passed.
Based on the results of the testing described above, it is concluded that the modifications to the Powerheart AED do not raise any new questions regarding the safety or effectiveness as compared with the predicate device. The Cardiac Science, Inc. Powerheart AED is substantially equivalent to the Powerheart AED cleared in K052161 and FirstSave STAR Biphasic AED cleared in K010214 in terms of indications for use, features and functions.
Confidential
5
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird-like figure.
Public Health Service
SEP 1 0 2009
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Cardiac Science Corporation c/o Ms. Beverly Magrane Sr. Manager RA/RC 3303 Monte Villa Pkwy. Bothell, WA 98021
K091943 Re:
Trade/Device Name: 9055 Electrode Adapter Cable Regulation Number: 21 CFR 870.5310 Regulation Name: Automated external defibrillator Regulatory Class: Class III (three) Product Code: MKJ Dated: August 25, 2009 Received: August 27, 2009
Dear Ms. Magrane:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Beverly Magrane
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
W.M.P.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
K0919443
Indications for Use Statement
510(k) Number:
Device Name: Powerheart® AED G3 (Model 9390E), Powerheart® AED G3 Automatic (Model 9390A)
Indications for Use:
The Powerheart AED G3 and the Powerheart AED G3 Automatic devices are intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physicianauthorized emergency medical response.
The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Postresuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of ECG rhythm. If a shockable ventricular tachyarrhythmia recurs, the device will charge automatically and advise the operator to deliver therapy (G3) or automatically deliver the charge (G3 Automatic).
When the patient is a child or infant up to 8 years of age, or up to 55 lbs (25kg), the device should be used with the Model 9730 Pediatric Attenuated Defibrillation Electrodes. The therapy should not be delayed to determine the patient's exact age or weight.
Prescription Use (Per 21 CFR 801.109) OR
Over-The Counter Use
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) |
|---|
| Division of Cardiovascular Devices |
| 510(k) Number | K091943 |
|---|---|
| --------------- | --------- |